Reaction

Faeces Hard reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 3,833 reports · 119 co-occurring drugs

As of the last recalculation, Faeces Hard appears in 3,833 FAERS reports alongside 119 co-occurring drug terms. The strongest observed disproportionality signal is TEDUGLUTIDE (PRR 41.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Teduglutide	100	41.4	41.7
Patiromer	71	28.4	28.5
Linaclotide	117	24.5	24.6
Psyllium Husk	37	20.5	20.6
Polyethylene Glycol 3350	303	18.6	18.7
Niraparib	69	17.2	17.2
Dimenhydrinate	31	15.9	16.0
Lubiprostone	22	12.7	12.7
Instalax Polyethylene Glycol 3350	28	12.3	12.4
Polyethylene Glycol 400	28	12.1	12.1
Vedolizumab	178	11.7	11.7
Orlistat	55	11.7	11.7
Infliximab-Dyyb	56	10.5	10.6
Magnesium Hydroxide	26	10.5	10.6
Octreotide Acetate	55	9.9	9.9
Naltrexone Hydrochloride And Bupropion Hydrochloride	15	9.6	9.6
Diphenoxylate Hydrochloride And Atropine Sulfate	21	8.4	8.4
Rivastigmine	27	7.8	7.8
Nintedanib	43	7.5	7.5
Loperamide Hydrochloride Oral	14	7.5	7.5
Docusate Sodium 100Mg	32	7.3	7.3
Loperamide Hydrochloride And Dimethicone	40	6.8	6.8
Loperamide Hcl	16	6.8	6.8
Loperamide Hydrochloride	55	6.8	6.8
Docusate Sodium	70	6.7	6.7
Mesalamine	67	6.6	6.6
Abemaciclib	24	6.6	6.6
Phytonadione	10	6.4	6.4
Rotigotine	17	6.4	6.4
Ropinirole	18	6.4	6.4
Vibegron	9	6.1	6.1
Pancrelipase	43	6.1	6.1
Docusate Sodium - Sennosides	34	5.8	5.8
Sevelamer Carbonate	12	5.7	5.7
Standardized Senna Concentrate	13	5.6	5.6
Relugolix	24	5.6	5.6
Lanreotide Acetate	8	5.6	5.6
Bisacodyl	14	5.4	5.4
Magnesium	80	5.4	5.4
Pramipexole	15	5.3	5.3
Pantoprazole Sodium In 0.9% Sodium Chloride	59	5.2	5.2
Pantoprazole Sodium Injection	59	5.2	5.2
Exenatide	49	5.1	5.1
Iron	61	5.0	5.0
Diltiazem Hydrochloride Extended-Release Tablets	10	4.8	4.8
Calcium	126	4.7	4.7
Drs. Clotrimazole	10	4.7	4.7
Family Wellness Clotrimazole	10	4.7	4.7
Clotrimazole Topical	10	4.7	4.7
Bisacodyl Suppositories	11	4.6	4.6
Biscodyl	11	4.6	4.6
Clotrimazole	10	4.4	4.4
Sennosides 8.6 Mg Tablets	17	4.4	4.4
Senna	17	4.4	4.4
Carbidopa And Levodopa	38	4.4	4.4
Bicalutamide	12	4.3	4.3
Lactulose	30	4.3	4.3
Senna Leaf	18	4.3	4.3
Umeclidinium	7	4.3	4.3
Sodium Bicarbonate	18	4.2	4.2
Sodium Bicarbonate Injection,	18	4.2	4.2
Regorafenib	9	4.2	4.2
Levodopa	9	4.1	4.1
Dabrafenib	15	3.9	3.9
Sennosides	21	3.8	3.8
Oral Semaglutide	50	3.7	3.7
Indapamide	12	3.6	3.6
Oxazepam	14	3.5	3.5
Enzalutamide	38	3.5	3.5
Amlodipine Besylate And Benazepril Hydrochloride	6	3.5	3.5
Cabozantinib	31	3.5	3.5
Fesoterodine Fumarate	7	3.5	3.5
Carboxymethylcellulose Sodium	6	3.5	3.5
Trametinib	15	3.4	3.4
Raloxifene Hydrochloride	9	3.4	3.4
Apalutamide	7	3.2	3.2
Calcium, Magnesium, Potassium, And Sodium Oxybates	5	3.2	3.2
Azelastine	10	3.0	3.0
Mirabegron	21	3.0	3.0
Sorafenib	11	2.9	2.9
Teriparatide	59	2.9	2.9
Rifaximin	11	2.9	2.9
Riociguat	17	2.8	2.8
Ruxolitinib	37	2.8	2.8
Ribociclib	16	2.8	2.8
Timolol	6	2.7	2.7
Glipizide	30	2.7	2.7
Methadone	21	2.7	2.7
Pegaspargase	6	2.7	2.7
Alpelisib	4	2.5	2.5
Peginterferon Alfa-2A	24	2.4	2.4
Acalabrutinib	5	2.2	2.2
Sunitinib Malate	15	2.1	2.1
Loratadine And Pseudoephedrine Sulfate	3	2.0	2.0
Abaloparatide	11	2.0	2.0
Naproxen Sodium Tablet	19	2.0	2.0
Risankizumab-Rzaa	29	1.9	1.9
Tirzepatide	57	1.9	1.9
Fremanezumab-Vfrm	4	1.9	1.9
Tolvaptan	5	1.9	1.9
Dulaglutide	30	1.8	1.8
Diroximel Fumarate	4	1.8	1.8
Olaparib	7	1.8	1.8
Avapritinib	4	1.8	1.8
Dasatinib	12	1.8	1.8
Elexacaftor, Tezacaftor, And Ivacaftor	4	1.7	1.7
Palbociclib	27	1.5	1.5
Trifluridine And Tipiracil	3	1.5	1.5
Glecaprevir And Pibrentasvir	3	1.5	1.5
Voxelotor	6	1.5	1.5
Hydrocodone Bitartrate And Acetaminophen	15	1.4	1.4
Pomalidomide	27	1.4	1.4
Ledipasvir And Sofosbuvir	5	1.4	1.4
Osimertinib	7	1.2	1.2
Erenumab-Aooe	12	1.2	1.2
Dornase Alfa	4	1.1	1.1
Pirfenidone	7	0.9	0.9
Nirmatrelvir And Ritonavir	7	0.7	0.7
Cinacalcet Hydrochloride	6	0.7	0.7

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.